Patents by Inventor Liang-Ji Zhou

Liang-Ji Zhou has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antibodies to lymphocyte activation antigens and uses therefor
    Patent number: 6068984
    Abstract: HB15-related lymphocyte activation antigens, and nucleic acid sequences encoding HB15-related antigens are disclosed. Also disclosed are antibodies reactive with HB15.
    Type: Grant
    Filed: January 30, 1998
    Date of Patent: May 30, 2000
    Assignee: Dana-Farber Cancer Institute, Inc.
    Inventors: Thomas Tedder, Liang-Ji Zhou
  • Culturing monocytes with IL-4, TNF-.alpha. and GM-CSF TO induce differentiation to dendric cells
    Patent number: 5849589
    Abstract: Disclosed is a method for inducing the differentiation of a monocyte into a dendritic cell, the method including the culturing of a monocyte in a medium including GM-CSF, IL-4, and TNF-.alpha..
    Type: Grant
    Filed: March 11, 1996
    Date of Patent: December 15, 1998
    Assignee: Duke University
    Inventors: Thomas F. Tedder, Liang-Ji Zhou
  • Lymphocyte activation antigens and antibodies thereto
    Patent number: 5766570
    Abstract: HB15-related lymphocyte activation antigens, and nucleic acid sequences encoding HB15-related antigens are disclosed. Also disclosed are antibodies reactive with HB15.
    Type: Grant
    Filed: April 24, 1995
    Date of Patent: June 16, 1998
    Assignee: Dana-Farber Cancer Institute, Inc.
    Inventors: Thomas F. Tedder, Liang-Ji Zhou
  • Nucleic acid encoding HB15 polypeptides
    Patent number: 5710262
    Abstract: HB15-related lymphocyte activation antigens, and nucleic acid sequences encoding HB15-related antigens are disclosed. Also disclosed are antibodies reactive with HB15.
    Type: Grant
    Filed: April 25, 1994
    Date of Patent: January 20, 1998
    Assignee: Dana-Faber Cancer Institute, Inc.
    Inventors: Thomas F. Tedder, Liang-Ji Zhou
  • Lymphocyte activation antigen HB15, a member of the immunoglobulin superfamily
    Patent number: 5316920
    Abstract: Lymphocyte activation antigen HB15, and the human cDNA and gene sequences encoding HB15, are disclosed. HB15 is not expressed at detectable levels by circulating leukocytes but has a unique pattern of expression among tissues. HB15 is uniquely expressed by Langerhans cells within the skin and other subpopulations of dendritic cells. Also disclosed are antibodies reactive with HB15 and methods of using anti-HB15 antibodies, or other antagonists to HB15 function, to treat an immunological disorder, disease or syndrome.
    Type: Grant
    Filed: April 17, 1992
    Date of Patent: May 31, 1994
    Assignee: Dana-Faber Cancer Institute, Inc.
    Inventors: Thomas F. Tedder, Liang-Ji Zhou